Literature DB >> 30717041

Treatment of only the fractional curve for radiculopathy in adult scoliosis: comparison to lower thoracic and upper thoracic fusions.

Dominic Amara1, Praveen V Mummaneni1, Christopher P Ames1, Bobby Tay2, Vedat Deviren2, Shane Burch2, Sigurd H Berven2, Dean Chou1.   

Abstract

OBJECTIVEMany options exist for the surgical management of adult spinal deformity. Radiculopathy and lumbosacral pain from the fractional curve (FC), typically from L4 to S1, is frequently a reason for scoliosis patients to pursue surgical intervention. The purpose of this study was to evaluate the outcomes of limited fusion of the FC only versus treatment of the entire deformity with long fusions.METHODSAll adult scoliosis patients treated at the authors' institution in the period from 2006 to 2016 were retrospectively analyzed. Patients with FCs from L4 to S1 > 10° and radiculopathy ipsilateral to the concavity of the FC were eligible for study inclusion and had undergone three categories of surgery: 1) FC only (FC group), 2) lower thoracic to sacrum (LT group), or 3) upper thoracic to sacrum (UT group). Primary outcomes were the rates of revision surgery and complications. Secondary outcomes were estimated blood loss, length of hospital stay, and discharge destination. Spinopelvic parameters were measured, and patients were stratified accordingly.RESULTSOf the 99 patients eligible for inclusion in the study, 27 were in the FC group, 46 in the LT group, and 26 in the UT group. There were no significant preoperative differences in age, sex, smoking status, prior operation, FC magnitude, pelvic tilt (PT), sagittal vertical axis (SVA), coronal balance, pelvic incidence-lumbar lordosis (PI-LL) mismatch, or proportion of well-aligned spines (SVA < 5 cm, PI-LL mismatch < 10°, and PT < 20°) among the three treatment groups. Mean follow-up was 30 (range 12-112) months, with a minimum 1-year follow-up. The FC group had a lower medical complication rate (22% [FC] vs 57% [LT] vs 58% [UT], p = 0.009) but a higher rate of extension surgery (26% [FC] vs 13% [LT] vs 4% [UT], p = 0.068). The respective average estimated blood loss (592 vs 1950 vs 2634 ml, p < 0.001), length of hospital stay (5.5 vs 8.3 vs 8.3 days, p < 0.001), and rate of discharge to acute rehabilitation (30% vs 46% vs 85%, p < 0.001) were all lower for FC and highest for UT.CONCLUSIONSTreatment of the FC only is associated with a lower complication rate, shorter hospital stay, and less blood loss than complete scoliosis treatment. However, there is a higher associated rate of extension of the construct to the lower or upper thoracic levels, and patients should be counseled when considering their options.

Entities:  

Keywords:  ASA = American Society of Anesthesiologists; CVA = coronal vertical axis; FC = fractional curve; HRQOL = health-related quality of life; LC = lower thoracic; LL = lumbar lordosis; PI = pelvic incidence; PI-LL = pelvic incidence–lumbar lordosis; PJK = proximal junctional kyphosis; PT = pelvic tilt; SVA = sagittal vertical axis; TLIF = transforaminal lumbar interbody fusion; UT = upper thoracic; deformity; fractional curve; radiculopathy; scoliosis

Year:  2019        PMID: 30717041     DOI: 10.3171/2018.9.SPINE18505

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  3 in total

1.  Improvement of coronal alignment in fractional low lumbar curves with the use of anterior interbody devices.

Authors:  Benjamin Geddes; Steven D Glassman; Tino Mkorombindo; Jonathan Q Gardner; Leah Y Carreon
Journal:  Spine Deform       Date:  2021-03-19

2.  The "Kickstand Rod" Technique for Coronal Imbalance in Patients With Spinal Deformity: A Case Report With Review of Literature.

Authors:  Brian Fiani; Ryan M Jarrah
Journal:  Cureus       Date:  2020-12-03

3.  Utility of the MISDEF2 Algorithm and Extent of Fusion in Open Adult Spinal Deformity Surgery With Minimum 2-Year Follow-up.

Authors:  Bo Li; Gregory Hawryluk; Praveen V Mummaneni; Michael Wang; Ratnesh Mehra; Minghao Wang; Darryl Lau; Rory Mayer; Kai-Ming Fu; Dean Chou
Journal:  Neurospine       Date:  2021-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.